Literature DB >> 27889294

Increasing the Detection of Familial Hypercholesterolaemia Using General Practice Electronic Databases.

Alistair W Vickery1, Jackie Ryan2, Jing Pang2, Jacquie Garton-Smith3, Gerald F Watts2.   

Abstract

BACKGROUND: Familial hypercholesterolaemia (FH) is a common autosomal co-dominant condition that causes premature cardiovascular disease. Awareness of FH is poor and only 10-15% of the affected population is identified. Electronic health records provide an opportunity to increase detection and awareness in general practice
OBJECTIVE: To determine whether a simple electronic extraction tool can increase detection of FH in general practice.
METHOD: An extraction tool applied to general practice electronic health records (EHR) to screen for FH, total cholesterol and low density lipoprotein cholesterol (LDL-c) levels in association with entered diagnostic criteria and demographic data in five general practices.
RESULTS: Of 157,290 active patients examined, 0.7% (n=1081) had an LDL-c>5.0 mmol/L representing 1 in 146 of active patients. An additional 0.8% (n=1276) patients were at possible risk of FH. Of those with an LDL-c>5.0 mmol/L 43.7% of patients had no record of being prescribed statins. Twenty patients (0.013%) had a clinical diagnosis of FH entered in the EHR.
CONCLUSIONS: Patients at high risk of FH can be identified by a simple electronic screening method in general practice. Clinical data entry is variable in general practice. Targeted screening enables clinical assessment of patients at risk of cardiovascular disease and using the DLCNS will enable primary care to increase identification of FH. Approximately one in five patients extracted using this method, are likely to have phenotypically probable FH, making it a useful screening tool.
Copyright © 2016 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). All rights reserved.

Entities:  

Keywords:  Electronic health records; Familial hypercholesterolaemia; General practice

Mesh:

Substances:

Year:  2016        PMID: 27889294     DOI: 10.1016/j.hlc.2016.09.012

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  12 in total

Review 1.  Leveraging Healthcare System Data to Identify High-Risk Dyslipidemia Patients.

Authors:  Nayrana Griffith; Grace Bigham; Aparna Sajja; Ty J Gluckman
Journal:  Curr Cardiol Rep       Date:  2022-08-22       Impact factor: 3.955

Review 2.  Strategies for screening for familial hypercholesterolaemia in primary care and other community settings.

Authors:  Nadeem Qureshi; Maria Luisa R Da Silva; Hasidah Abdul-Hamid; Stephen F Weng; Joe Kai; Jo Leonardi-Bee
Journal:  Cochrane Database Syst Rev       Date:  2021-10-07

3.  How well can familial hypercholesterolemia be identified in an electronic health record database?

Authors:  Katherine E Mues; Alina N Bogdanov; Keri L Monda; Larisa Yedigarova; Alexander Liede; Lee Kallenbach
Journal:  Clin Epidemiol       Date:  2018-11-15       Impact factor: 4.790

4.  Variation in Documenting Diagnosable Chronic Kidney Disease in General Medical Practice: Implications for Quality Improvement and Research.

Authors:  Alex Kitsos; Gregory M Peterson; Matthew D Jose; Masuma Akter Khanam; Ronald L Castelino; Jan C Radford
Journal:  J Prim Care Community Health       Date:  2019 Jan-Dec

Review 5.  Systematic Identification of Familial Hypercholesterolaemia in Primary Care-A Systematic Review.

Authors:  Luisa Silva; Nadeem Qureshi; Hasidah Abdul-Hamid; Stephen Weng; Joe Kai; Jo Leonardi-Bee
Journal:  J Pers Med       Date:  2021-04-15

Review 6.  Familial Hypercholesterolemia in Asia Pacific: A Review of Epidemiology, Diagnosis, and Management in the Region.

Authors:  Sanjay Kalra; Zhenyue Chen; Chaicharn Deerochanawong; Kou-Gi Shyu; Ru San Tan; Brian Tomlinson; Hung-I Yeh
Journal:  J Atheroscler Thromb       Date:  2021-03-19       Impact factor: 4.928

7.  An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the "Ten Countries Study".

Authors:  Jing Pang; Miao Hu; Jie Lin; Takashi Miida; Hapizah M Nawawi; Jeong Euy Park; Xue Wu; Anis S Ramli; Ngoc Thanh Kim; See Kwok; Lourdes E Gonzalez-Santos; Ta-Chen Su; Thanh Huong Truong; Handrean Soran; Shizuya Yamashita; Brian Tomlinson; Gerald F Watts
Journal:  BMJ Open       Date:  2017-10-25       Impact factor: 2.692

Review 8.  Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis.

Authors:  Leo E Akioyamen; Jacques Genest; Shubham D Shan; Rachel L Reel; Jordan M Albaum; Anna Chu; Jack V Tu
Journal:  BMJ Open       Date:  2017-09-01       Impact factor: 2.692

9.  Evaluating a clinical tool (FAMCAT) for identifying familial hypercholesterolaemia in primary care: a retrospective cohort study.

Authors:  Ralph K Akyea; Nadeem Qureshi; Joe Kai; Simon de Lusignan; Julian Sherlock; Christopher McGee; Stephen Weng
Journal:  BJGP Open       Date:  2020-12-15

10.  The evaluation and management of patients with LDL-C ≥ 190 ​mg/dL in a large health care system.

Authors:  Candace L Jackson; Zahid Ahmad; Sandeep R Das; Amit Khera
Journal:  Am J Prev Cardiol       Date:  2020-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.